Advertisement
Advertisement
ATRC
AtriCure, Inc.
29.04
USDSponsored
+0.04
+0.12%
May 21, 12:36 UTC -4
Open
ATRC Earnings Reports
Positive Surprise Ratio
ATRC beat 32 of 42 last estimates.
76%
Next Report
Date of Next Report
Jul 27, 2026
Estimate for Q2 26 (Revenue/ EPS)
$155.09M
/$0.01
Implied change from Q1 26 (Revenue/ EPS)
+9.80%
/--
Implied change from Q2 25 (Revenue/ EPS)
+13.92%
/-150.00%
AtriCure, Inc. earnings per share and revenue
On May 05, 2026, ATRC reported earnings of 0.00 USD per share (EPS) for Q1 26, beating the estimate of -0.06 USD, resulting in a 100.00% surprise. Revenue reached 141.25 million, compared to an expected 142.61 million, with a -0.95% difference. The market reacted with a -4.70% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 11 analysts forecast an EPS of 0.01 USD, with revenue projected to reach 155.09 million USD, implying an -- of --% EPS, and increase of 9.80% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Omeros Corporation
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.41
Actual
-$0.24
Surprise
+41.90%
Brainsway Ltd. - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
$0.17
Actual
$0.18
Surprise
+6.98%
Valneva SE - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.18
Surprise
-154.60%
MacroGenics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.58
Actual
-$0.57
Surprise
+0.45%
FitLife Brands, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.12
Actual
$0.17
Surprise
+33.33%
Immucell Corp
Report Date
May 14, 2026 For Q1 26
Estimate
-Actual
$0.21
Surprise
-
Veru Inc.
Report Date
May 13, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.12
Surprise
+58.72%
Bonk, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.23
Surprise
-
Cellectar Biosciences INC NEW
Report Date
May 14, 2026 For Q1 26
Estimate
-$1.92
Actual
-$1.30
Surprise
+32.39%
Innovative Eyewear, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.47
Actual
-$0.37
Surprise
+22.82%
FAQ
What were AtriCure, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, AtriCure, Inc. reported EPS of $0.00, beating estimates by 100%, and revenue of $141.25M, -0.95% below expectations.
How did the market react to AtriCure, Inc.'s Q1 2026 earnings?
The stock price moved down -4.7%, changed from $29.39 before the earnings release to $28.01 the day after.
When is AtriCure, Inc. expected to report next?
The next earning report is scheduled for Jul 27, 2026.
What are the forecasts for AtriCure, Inc.'s next earnings report?
Based on 11
analysts, AtriCure, Inc. is expected to report EPS of $0.01 and revenue of $155.09M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement